Bone Morphogenic Protein Receptor type 2 mutation carriers research hub

Targeting fibrotic tissue with a radioactive-labelled Fibrobody, visible using a full-body PET/CT scan (FibroVision)

The FibroVision study is testing a new type of medical scan to detect organ scarring, also known as fibrosis. Participants receive a small injection of a specialised tracer called a Fibrobody, followed by a full-body PET/CT scan. Researchers want to find out if this scan is safe and effective.